Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses

Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non–Small-Cell Lung Cancer?: A Pooled Analysis of the Literature

(2013) Kazuyuki Tsujino et al.   Journal of Thoracic Oncology

Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

(2013) Gregory T Wurz et al.   Journal of Translational Medicine

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

(2013) Charles Butts et al.   LANCET ONCOLOGY

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

(2012) Yanwen Yao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer

(2011) Sonosuke Tanaka et al.   INTERNATIONAL JOURNAL OF CANCER

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

(2011) Charles Butts et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

(2011) Naohiro Kobayashi et al.   LUNG CANCER

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

(2010) Anne Aupérin et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer

(2010) Dongrong Situ et al.   MEDICAL ONCOLOGY

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

(2008) Nobuhisa Ishikawa et al.   INTERNATIONAL JOURNAL OF CANCER